Integer Holdings ITGR stock price drops 31% on October 23 2025 due to slow medical product sales

Integer Holdings (ITGR) shares lost over 30% of their value in one day. This is a much bigger drop than the small dip seen in July 2025 because customers are not using new medical tech fast enough.
By Newsroom | Business, USA |

On October 23, 2025, Integer Holdings Corp (ITGR) shares suffered a jagged collapse, falling between 31.4% and 40% as the company’s internal math failed to meet external hopes. Incoming CEO Payman Khales effectively cooled the room during the Q3 earnings call by warning that product adoption is dragging. While the company claimed momentum, the reality is a sharp downward revision for the coming quarters.

"A recent shift in customer demand for certain products will weigh on the financial performance over the next few quarters." — Payman Khales, Incoming CEO.

The core of the decay sits in the Cardiac Rhythm Management & Neuromodulation (CRM&N) segment. New medical tech isn't moving because emerging customers with pre-market approval (PMA) products are backing off. The gap between "innovation" and "sales" has become a chasm that investors decided they no longer wanted to jump.

The Disconnect of the "Strong" Report

The sell-off feels lopsided because the Q3 numbers themselves weren't entirely hollow. However, the forward-looking guidance acted as a poison pill for the stock price.

Read More: Elon Musk's Terafab to Make Chips for Tesla and SpaceX by 2025

  • EBITDA Friction: Even when earnings per share hit the marks, the EBITDA (the raw cash-generating image of a company) often fails to satisfy those looking for a clean growth story.

  • Sentiment Gap: While the price burned, retail sentiment on social platforms like Stocktwits inexplicably flipped to "extremely bullish," suggesting a weird decoupling between people typing on phones and people moving large blocks of institutional capital.

  • Adoption Lag: Customers are taking a slow, shaky path to integrate Integer’s new offerings, allowing rivals with bigger portfolios to hover nearby.

Performance Comparison: Expectations vs. Outcomes

MetricThe ClaimThe Reality
Q3 EarningsGrowth momentum was "highlighted"Shares fell 31% instantly
Product AdoptionNew tech is the futurePMA customers are buying less
CEO TransitionNew leadership (Khales)Immediate warning of "weighing" performance
Retail SentimentExtremely BullishStock price hit a yearly low

A Pattern of Broken Ceilings

This isn't the first time the company's story has frayed at the edges. Back in July 2025, the stock tripped over a similar miss on EBITDA, even though they tried to lift their full-year profit forecasts at the time. The market seems to have a long memory for these "strong" reports that leave out the messy details of operational costs.

The medical device industry is often called "resilient," but for Integer, the innovation pipeline is currently a liability. When the "moat" around a company consists of products that customers are hesitant to adopt, the moat starts to look more like a drain. Investors are now left watching to see if this is a temporary dip or a permanent downshift in how the market values the company's shaky hardware bets.

Frequently Asked Questions

Q: Why did Integer Holdings ITGR stock price fall by 31% on October 23 2025?
The stock price fell because the company said sales for new medical products are moving very slowly. New CEO Payman Khales told investors that the company will make less money in the next few months than they first thought.
Q: Which medical products caused the Integer Holdings ITGR stock crash in October 2025?
The problem is with tools used for heart rhythm and nerve treatments. Customers who make these medical devices are not buying as many parts from Integer as they used to.
Q: What did CEO Payman Khales say about Integer Holdings' future during the Q3 2025 meeting?
Payman Khales said that a change in what customers want will hurt the company's money for the next few quarters. He warned that it is taking a long time for people to start using their new technology.
Q: How does the October 2025 Integer Holdings stock drop compare to the July 2025 report?
In July 2025, the stock also went down because of high costs, but the October drop of 31% is much worse. Investors are now more worried because the company lowered its goals for how much money it will make.